Biotech Company Discloses $40 Million Investment From Sanofi
Sanofi is set to invest $40 million in Vigil Neuroscience, purchasing shares at an as-converted rate of $7.44 per common share (5.20).
Disclaimer: This article is for informational purposes only and does not constitute an endorsement or commercial promotion of Vigil Neuroscience, Inc. or its products.
Real-time information is available daily at https://stockregion.net